Inflammation Following Ocular Surgery

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
Generic Loteprednol EtabonatePhase 11 trial
Active Trials
NCT03531697CompletedEst. Oct 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SandozGeneric Loteprednol Etabonate

Clinical Trials (1)

NCT03531697SandozGeneric Loteprednol Etabonate

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

Start: Apr 2018Est. completion: Oct 2019
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space